Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ischemic Attack, Transient | 1 | 2022 | 57 | 0.800 |
Why?
|
| Atrial Fibrillation | 3 | 2022 | 657 | 0.620 |
Why?
|
| Surgical Stapling | 1 | 2018 | 18 | 0.600 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2018 | 49 | 0.580 |
Why?
|
| Stroke | 2 | 2022 | 979 | 0.530 |
Why?
|
| Pacemaker, Artificial | 1 | 2018 | 173 | 0.500 |
Why?
|
| Defibrillators, Implantable | 1 | 2018 | 190 | 0.500 |
Why?
|
| Heart Neoplasms | 2 | 2012 | 101 | 0.460 |
Why?
|
| Myxoma | 1 | 2012 | 29 | 0.390 |
Why?
|
| Catheter Ablation | 3 | 2020 | 233 | 0.330 |
Why?
|
| Heart Ventricles | 2 | 2020 | 777 | 0.310 |
Why?
|
| Heart Arrest | 1 | 2012 | 357 | 0.280 |
Why?
|
| Anticoagulants | 2 | 2022 | 577 | 0.230 |
Why?
|
| Hyperthyroidism | 1 | 2020 | 26 | 0.170 |
Why?
|
| Tachycardia, Ventricular | 2 | 2020 | 192 | 0.170 |
Why?
|
| Syncope | 2 | 2013 | 51 | 0.130 |
Why?
|
| Vitamin K | 1 | 2015 | 37 | 0.120 |
Why?
|
| Electric Countershock | 1 | 2015 | 67 | 0.120 |
Why?
|
| Rivaroxaban | 1 | 2015 | 54 | 0.110 |
Why?
|
| Factor Xa Inhibitors | 1 | 2015 | 64 | 0.110 |
Why?
|
| Thromboembolism | 1 | 2015 | 89 | 0.110 |
Why?
|
| Theophylline | 1 | 2013 | 29 | 0.110 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 193 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2022 | 16344 | 0.100 |
Why?
|
| Ventricular Septum | 1 | 2012 | 16 | 0.100 |
Why?
|
| Electrocardiography | 2 | 2020 | 976 | 0.100 |
Why?
|
| Sarcoidosis | 1 | 2012 | 60 | 0.100 |
Why?
|
| Hemorrhage | 1 | 2015 | 467 | 0.090 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2012 | 240 | 0.090 |
Why?
|
| Middle Aged | 6 | 2018 | 26807 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2012 | 378 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 319 | 0.080 |
Why?
|
| Echocardiography | 2 | 2012 | 1060 | 0.080 |
Why?
|
| Endocarditis | 1 | 2010 | 106 | 0.080 |
Why?
|
| Aneurysm, False | 1 | 2010 | 93 | 0.080 |
Why?
|
| Mitral Valve | 1 | 2010 | 251 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 503 | 0.070 |
Why?
|
| Humans | 10 | 2022 | 125331 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2012 | 500 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 2089 | 0.070 |
Why?
|
| Ultrasonic Therapy | 1 | 2007 | 29 | 0.070 |
Why?
|
| Aortic Valve | 1 | 2010 | 442 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 1 | 2007 | 176 | 0.070 |
Why?
|
| Male | 7 | 2018 | 61573 | 0.060 |
Why?
|
| Ischemia | 1 | 2007 | 351 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2006 | 374 | 0.050 |
Why?
|
| Aged | 2 | 2018 | 19728 | 0.050 |
Why?
|
| Adult | 2 | 2018 | 29607 | 0.040 |
Why?
|
| Comorbidity | 2 | 2013 | 1531 | 0.030 |
Why?
|
| Female | 2 | 2018 | 66836 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 1898 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2010 | 939 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 759 | 0.030 |
Why?
|
| Age Distribution | 1 | 2013 | 417 | 0.020 |
Why?
|
| Mediastinum | 1 | 2012 | 43 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2012 | 117 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 202 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2013 | 681 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2012 | 449 | 0.020 |
Why?
|
| Inpatients | 1 | 2013 | 500 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2013 | 1174 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2013 | 1027 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 2175 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2007 | 31 | 0.020 |
Why?
|
| Hindlimb | 1 | 2007 | 80 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2013 | 12290 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2007 | 97 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2007 | 182 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2007 | 198 | 0.020 |
Why?
|
| Rabbits | 1 | 2007 | 717 | 0.020 |
Why?
|
| Dobutamine | 1 | 2006 | 56 | 0.020 |
Why?
|
| Systole | 1 | 2006 | 201 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 139 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 1095 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2007 | 1637 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 3134 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6555 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2010 | 3439 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3603 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 9066 | 0.010 |
Why?
|
| United States | 1 | 2013 | 10922 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 10287 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 19419 | 0.010 |
Why?
|
| Animals | 1 | 2007 | 34298 | 0.000 |
Why?
|